Screener
Moderna MRNA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
Based on trailing twelve months.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's return on equity?
- Moderna (MRNA) reported return on equity of -39% in Q2 2026.
- How has Moderna's return on equity changed year-over-year?
- Moderna's return on equity decreased by 41.8% year-over-year, from -27.5% to -39%.
- What is the long-term trend for Moderna's return on equity?
- Over 5 years (2020 to 2025), Moderna's return on equity has grown at a -6.3% compound annual growth rate (CAGR), from -40% to -28.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Moderna's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude